🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/08/2009 | 29,58 | 29,67 | 29,12 | 29,56 | +0,00% | 1,84% | 16.942.178 |
| 13/08/2009 | 29,32 | 29,56 | 27,38 | 29,56 | +0,78% | 7,45% | 14.137.939 |
| 12/08/2009 | 28,95 | 29,57 | 28,63 | 29,33 | +1,35% | 3,26% | 12.899.518 |
| 11/08/2009 | 29,06 | 29,37 | 28,77 | 28,94 | -0,88% | 2,07% | 11.423.829 |
| 10/08/2009 | 28,90 | 29,58 | 28,73 | 29,20 | +1,66% | 2,94% | 19.050.963 |
| 07/08/2009 | 28,35 | 29,10 | 28,10 | 28,72 | +2,52% | 3,53% | 13.656.278 |
| 06/08/2009 | 28,32 | 28,32 | 27,91 | 28,02 | -0,84% | 1,45% | 11.499.494 |
| 05/08/2009 | 28,50 | 28,80 | 28,00 | 28,25 | -0,77% | 2,81% | 13.375.100 |
| 04/08/2009 | 28,76 | 28,88 | 28,13 | 28,47 | -0,60% | 2,62% | 16.077.892 |
| 03/08/2009 | 29,06 | 29,07 | 28,37 | 28,65 | +0,03% | 2,43% | 16.298.286 |
| 31/07/2009 | 28,82 | 29,18 | 28,54 | 28,64 | +0,23% | 2,22% | 16.269.362 |
| 30/07/2009 | 28,83 | 29,55 | 28,51 | 28,57 | +0,23% | 3,61% | 24.300.290 |
| 29/07/2009 | 28,64 | 28,76 | 28,16 | 28,50 | -0,50% | 2,10% | 16.696.736 |
| 28/07/2009 | 29,30 | 29,49 | 28,41 | 28,65 | -2,44% | 3,71% | 23.627.265 |
| 27/07/2009 | 29,69 | 29,75 | 29,03 | 29,36 | -0,71% | 2,44% | 21.026.758 |
| 24/07/2009 | 28,88 | 29,64 | 28,57 | 29,57 | +2,45% | 3,70% | 26.308.678 |
| 23/07/2009 | 28,17 | 29,24 | 28,12 | 28,86 | +2,72% | 3,96% | 26.678.517 |
| 22/07/2009 | 28,22 | 28,68 | 27,93 | 28,10 | -0,67% | 2,67% | 19.869.451 |
| 21/07/2009 | 27,41 | 28,43 | 27,27 | 28,29 | +6,12% | 4,21% | 27.961.059 |
| 20/07/2009 | 26,48 | 26,72 | 26,18 | 26,66 | +0,94% | 2,02% | 11.851.098 |
| 17/07/2009 | 26,56 | 26,59 | 26,15 | 26,41 | -0,68% | 1,65% | 11.335.273 |
| 16/07/2009 | 26,42 | 26,72 | 26,29 | 26,59 | +0,58% | 1,63% | 13.268.938 |
| 15/07/2009 | 26,09 | 26,49 | 25,59 | 26,44 | +2,03% | 3,44% | 21.509.886 |
| 14/07/2009 | 25,67 | 26,06 | 23,90 | 25,92 | +1,27% | 8,40% | 14.570.763 |
| 13/07/2009 | 25,21 | 25,67 | 24,93 | 25,59 | +1,40% | 2,91% | 16.515.222 |
| 10/07/2009 | 25,67 | 25,75 | 25,06 | 25,24 | -2,07% | 2,71% | 18.809.294 |
| 09/07/2009 | 26,49 | 26,62 | 25,36 | 25,77 | -3,67% | 4,75% | 28.109.980 |
| 08/07/2009 | 26,61 | 27,23 | 26,46 | 26,76 | +1,52% | 2,90% | 22.403.515 |
| 07/07/2009 | 26,57 | 27,09 | 26,26 | 26,36 | -0,97% | 3,12% | 23.592.995 |
| 06/07/2009 | 25,73 | 26,72 | 25,53 | 26,61 | +3,26% | 4,60% | 24.246.214 |